Secondary progressive multiple sclerosis (SPMS) is a later stage of the chronic disease multiple sclerosis MS.
Most people with MS start out with a clinical course characterized by episodes or attacks (relapses) of neurologic dysfunction, which occur over many years. This is called the relapsing-remitting phase. Symptoms of such relapses include vision loss or double vision, numbness/tingling in the extremities, muscle weakness, slurred speech, difficulty with coordination, and bladder dysfunction. Unlike the first phases of MS, SPMS gets steadily worse and relapses are no longer likely. SPMS can be difficult to diagnose.
Limited approved MS and SPMS therapies are currently available. Meridian is conducting a Phase III clinical trial for an investigational medication for people with SPMS.
Must be age 18 to 60
Must be diagnosed with SPMS
Must have an absence of clinical relapses for 24 months
Must have documented evidence of 12 months of disability progression
May receive compensation for time and travel
Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 354-7676.
Submit your information
Meridian Clinical Research
6602 Waters Avenue, Building C
Savannah, GA 31406
After you submit your information, a Meridian enrollment specialist will contact you.
Participating in a study is an important decision — we’re here to help you before, during, and after studies.
Please note: Health insurance is NOT required to join.
Will I benefit from this study?
You are not guaranteed to benefit from being in a clinical study. However, information gathered in this study may help uncover better ways to treat condition(s) for you and others worldwide.
Is participation voluntary after I submit my information?
Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, your role in the trial, potential side effects, tests that will be performed, and the number of visits required. You will need to sign an informed consent form to join the study only after you fully understand your role in the study.
Will I get a physical exam?
Participants will receive a physical exam and may also receive specific exams or tests.
Will I receive compensation?
While participation in a clinical study is voluntary, you may be reimbursed for your study-related travel and expenses. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible reimbursement with you.
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.